Zinc deficiency or excess within the physiological range increases genome instability and cytotoxicity, respectively, in human oral keratinocyte cells.

Razinah Sharif, Philip Thomas, Peter Zalewski, Michael Fenech
Author Information
  1. Razinah Sharif: CSIRO Food and Nutritional Sciences, Adelaide, SA, Australia.

Abstract

Zinc (Zn) is an essential component of Zn-finger proteins and acts as a cofactor for enzymes required for cellular metabolism and in the maintenance of DNA integrity. The study investigated the genotoxic and cytotoxic effects of Zn deficiency or excess in a primary human oral keratinocyte cell line and determined the optimal concentration of two Zn compounds (Zn Sulphate (ZnSO(4)) and Zn Carnosine (ZnC)) to minimise DNA damage. Zn-deficient medium (0 μM) was produced using Chelex treatment, and the two Zn compounds ZnSO(4) and ZnC were tested at concentrations of 0.0, 0.4, 4.0, 16.0, 32.0 and 100.0 μM. Cell viability was decreased in Zn-depleted cells (0 μM) as well as at 32 μM and 100 μM for both Zn compounds (P < 0.0001) as measured via the MTT assay. DNA strand breaks, as measured by the comet assay, were found to be increased in Zn-depleted cells compared with the other treatment groups (P < 0.05). The Cytokinesis Block Micronucleus Cytome assay showed a significant increase in the frequency of both apoptotic and necrotic cells under Zn-deficient conditions (P < 0.05). Furthermore, elevated frequencies of micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBuds) were observed at 0 and 0.4 μM Zn, whereas these biomarkers were minimised for both Zn compounds at 4 and 16 μM Zn (P < 0.05), suggesting these concentrations are optimal to maintain genome stability. Expression of PARP, p53 and OGG1 measured by western blotting was increased in Zn-depleted cells indicating that DNA repair mechanisms are activated. These results suggest that maintaining Zn concentrations within the range of 4-16 μM is essential for DNA damage prevention in cultured human oral keratinocytes.

References

  1. Biochim Biophys Acta. 1998 Mar 12;1380(1):46-54 [PMID: 9545530]
  2. Curr Drug Targets. 2006 May;7(5):607-627 [PMID: 16719771]
  3. Crit Rev Food Sci Nutr. 1994;34(4):403-26 [PMID: 7945896]
  4. Crit Rev Oral Biol Med. 2000;11(4):383-408 [PMID: 11132762]
  5. Nutrition. 1999 Oct;15(10):744-8 [PMID: 10501286]
  6. J Nutr Biochem. 2004 Oct;15(10):572-8 [PMID: 15542347]
  7. J Nutr. 2003 Mar;133(3):948S-955S [PMID: 12612181]
  8. Am J Clin Nutr. 2006 Oct;84(4):946-7; author reply 947-8 [PMID: 17023726]
  9. Biol Trace Elem Res. 1997 Apr;57(1):91-6 [PMID: 9258472]
  10. Biochem Pharmacol. 2000 Feb 15;59(4):401-5 [PMID: 10644048]
  11. Biol Trace Elem Res. 2002 Aug;88(2):139-44 [PMID: 12296424]
  12. Mutagenesis. 2011 Mar;26(2):295-301 [PMID: 21044989]
  13. Proc Nutr Soc. 2008 May;67(2):146-56 [PMID: 18412988]
  14. Gut. 2007 Feb;56(2):168-75 [PMID: 16777920]
  15. Curr Biol. 2000 Oct 19;10(20):1299-302 [PMID: 11069113]
  16. Am J Physiol Cell Physiol. 2002 Aug;283(2):C631-8 [PMID: 12107073]
  17. Eur J Cancer B Oral Oncol. 1995 May;31B(3):155-9 [PMID: 7549753]
  18. Lipids. 1994 Jul;29(7):461-6 [PMID: 7968266]
  19. Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10859-64 [PMID: 19541612]
  20. Mutat Res. 2001 Oct 18;497(1-2):89-99 [PMID: 11525911]
  21. Nature. 1997 Feb 20;385(6618):740-3 [PMID: 9034193]
  22. Am J Physiol Lung Cell Mol Physiol. 2006 Mar;290(3):L433-41 [PMID: 16284213]
  23. J Natl Cancer Inst. 1987 Oct;79(4):687-91 [PMID: 3477659]
  24. Mutat Res. 2006 Aug 30;600(1-2):58-66 [PMID: 16822529]
  25. Nutrition. 2006 May;22(5):465-74 [PMID: 16472982]
  26. Biochem Biophys Res Commun. 1998 Jul 9;248(1):28-32 [PMID: 9675080]
  27. Biol Trace Elem Res. 2004 Sep;100(3):215-27 [PMID: 15467107]
  28. J BUON. 2010 Apr-Jun;15(2):337-9 [PMID: 20658732]
  29. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 [PMID: 6606682]
  30. IUBMB Life. 2005 Oct;57(10):661-9 [PMID: 16223705]
  31. J Nutr. 2008 Apr;138(4):667-73 [PMID: 18356318]
  32. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):751-8 [PMID: 8672992]
  33. J Gerontol A Biol Sci Med Sci. 2009 Jul;64(7):745-51 [PMID: 19359441]
  34. Arch Biochem Biophys. 2002 Sep 15;405(2):170-7 [PMID: 12220529]
  35. Mutat Res. 2002 Jul 25;504(1-2):131-6 [PMID: 12106653]
  36. J Nutr. 2003 Aug;133(8):2543-8 [PMID: 12888634]
  37. Breast Cancer Res Treat. 1999 Mar;54(1):59-64 [PMID: 10369081]
  38. Science. 1998 Nov 20;282(5393):1484-7 [PMID: 9822378]
  39. J Mol Biol. 2008 May 23;379(1):136-45 [PMID: 18436240]
  40. Exp Gerontol. 2008 May;43(5):409-14 [PMID: 18022337]
  41. Genet Mol Res. 2002 Sep 30;1(3):246-60 [PMID: 14963832]
  42. Am J Physiol Cell Physiol. 2001 Sep;281(3):C751-7 [PMID: 11502552]
  43. Cell Biol Int. 2009 Apr;33(4):542-7 [PMID: 19254773]
  44. Am J Clin Nutr. 2009 Aug;90(2):321-8 [PMID: 19515738]
  45. Biochem J. 1994 Dec 1;304 ( Pt 2):509-16 [PMID: 7998987]
  46. Infect Immun. 2002 Dec;70(12):7073-80 [PMID: 12438388]
  47. Genes Dev. 1997 Dec 15;11(24):3471-81 [PMID: 9407038]
  48. Gut. 2003 Sep;52(9):1304-7 [PMID: 12912862]
  49. Urol Oncol. 2006 Mar-Apr;24(2):122-30 [PMID: 16520276]
  50. Mutat Res. 2009 Aug;678(1):59-64 [PMID: 19607932]
  51. Free Radic Biol Med. 2001 Nov 15;31(10):1179-90 [PMID: 11705696]
  52. Tsitol Genet. 2004 May-Jun;38(3):72-5 [PMID: 15619992]
  53. Mutat Res. 1989 Dec;224(4):517-25 [PMID: 2685592]
  54. J Clin Biochem Nutr. 2010 Jan;46(1):43-51 [PMID: 20104264]
  55. Mutat Res. 2001 Apr 18;475(1-2):161-7 [PMID: 11295161]
  56. Exp Cell Res. 1988 Mar;175(1):184-91 [PMID: 3345800]
  57. J Neurochem. 2003 May;85(3):563-70 [PMID: 12694382]
  58. Wei Sheng Yan Jiu. 1998 May;27(3):173-4 [PMID: 10684124]
  59. Br J Nutr. 1986 Sep;56(2):395-405 [PMID: 3676220]
  60. J Immunol. 1994 Sep 1;153(5):2302-12 [PMID: 8051426]
  61. Arch Biochem Biophys. 2000 May 1;377(1):1-8 [PMID: 10775435]
  62. Int J Biochem Cell Biol. 1998 Aug;30(8):863-8 [PMID: 9744078]
  63. Toxicol Lett. 2010 May 19;195(1):23-30 [PMID: 20206247]
  64. Leukemia. 2010 Apr;24(4):679-86 [PMID: 20130602]
  65. Neurosci Lett. 1997 Dec 5;238(3):135-8 [PMID: 9464638]
  66. Mutagenesis. 2011 Jan;26(1):125-32 [PMID: 21164193]
  67. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16770-5 [PMID: 12481036]
  68. Immunol Cell Biol. 2001 Apr;79(2):170-7 [PMID: 11264713]
  69. Mutagenesis. 2011 Jan;26(1):69-76 [PMID: 21164185]
  70. Biochemistry. 2002 Feb 5;41(5):1689-94 [PMID: 11814364]
  71. Leuk Res. 2004 Oct;28(10):1013-21 [PMID: 15289012]
  72. Mutat Res. 2004 Sep;567(1):85-104 [PMID: 15341904]
  73. Radiat Res. 1990 Apr;122(1):86-94 [PMID: 2320728]
  74. DNA Repair (Amst). 2006 Sep 8;5(9-10):1082-92 [PMID: 16784900]
  75. J Nutr. 2009 Sep;139(9):1626-31 [PMID: 19625698]
  76. Nat Protoc. 2007;2(5):1084-104 [PMID: 17546000]
  77. Environ Mol Mutagen. 2000;35(3):206-21 [PMID: 10737956]
  78. Nucleic Acids Res. 1989 Jun 26;17(12):4689-98 [PMID: 2501758]
  79. Free Radic Biol Med. 2010 Jan 1;48(1):82-8 [PMID: 19836448]
  80. Membr Cell Biol. 1998;12(1):89-99 [PMID: 9829262]
  81. Placenta. 2007 Jan;28(1):22-30 [PMID: 16503348]
  82. Am J Clin Nutr. 2010 May;91(5):1438S-1454S [PMID: 20219957]
  83. J Nutr. 1985 Feb;115(2):252-62 [PMID: 3968590]
  84. Clin Cancer Res. 1997 Nov;3(11):1931-41 [PMID: 9815582]
  85. Mutat Res. 2011 Feb 28;720(1-2):22-33 [PMID: 21167308]
  86. J Gastroenterol. 2010 Jul;45(7):692-702 [PMID: 20174833]

Word Cloud

Created with Highcharts 10.0.0Zn0DNA4cellscompoundsP < 0humanoralconcentrationsZn-depletedmeasuredassay05ZincessentialdeficiencyexcesskeratinocyteoptimaltwoZnSOZnCdamageZn-deficient0 μMtreatmentincreasedgenomewithinrangecomponentZn-fingerproteinsactscofactorenzymesrequiredcellularmetabolismmaintenanceintegritystudyinvestigatedgenotoxiccytotoxiceffectsprimarycelllinedeterminedconcentrationSulphateCarnosineminimisemediumproducedusingChelextested1632100CellviabilitydecreasedμMwell32 μM100 μM0001viaMTTstrandbreakscometfoundcomparedgroupsCytokinesisBlockMicronucleusCytomeshowedsignificantincreasefrequencyapoptoticnecroticconditionsFurthermoreelevatedfrequenciesmicronucleiMNinucleoplasmicbridgesNPBsnuclearbudsNBudsobserved4 μMwhereasbiomarkersminimised16 μMsuggestingmaintainstabilityExpressionPARPp53OGG1westernblottingindicatingrepairmechanismsactivatedresultssuggestmaintaining4-16 μMpreventionculturedkeratinocytesphysiologicalincreasesinstabilitycytotoxicityrespectively

Similar Articles

Cited By